Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Benepali is first biosimilar etanercept recommended for approval in E.U.

Nov. 24, 2015

Galapagos begins phase I study of GLPG-1972

Nov. 24, 2015

Symic selects SB-061 as first osteoarthritis clinical candidate

Nov. 19, 2015

Preclinical and clinical results of SM-04690 for the treatment of osteoarthritis

Nov. 19, 2015

Phase I results for FPA-008 in RA

Nov. 18, 2015

First-in-patient data for anti-fractalkine MAb E-6011 in RA

Nov. 18, 2015

Long-term data for olokizumab in rheumatoid arthritis

Nov. 18, 2015

Phase I data for biosimilar adalimumab, BI-695501

Nov. 17, 2015

AstraZeneca starts phase I study of MEDI-7352 in patients with osteoarthritis

Nov. 17, 2015

NIP-565: a JAK-1 inhibitor for rheumatoid arthritis

Nov. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...